Christopher J. Damman

1.2k total citations · 1 hit paper
19 papers, 912 citations indexed

About

Christopher J. Damman is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Christopher J. Damman has authored 19 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Infectious Diseases and 4 papers in Genetics. Recurrent topics in Christopher J. Damman's work include Gut microbiota and health (9 papers), Clostridium difficile and Clostridium perfringens research (7 papers) and Inflammatory Bowel Disease (3 papers). Christopher J. Damman is often cited by papers focused on Gut microbiota and health (9 papers), Clostridium difficile and Clostridium perfringens research (7 papers) and Inflammatory Bowel Disease (3 papers). Christopher J. Damman collaborates with scholars based in United States, United Kingdom and Canada. Christopher J. Damman's co-authors include Timothy L. Zisman, David L. Suskind, Samuel I. Miller, Christina M. Surawicz, Stephen M. Vindigni, Michele L. Shaffer, Ghassan Wahbeh, Hillary S. Hayden, M. Brittnacher and Kyle R. Hager and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Christopher J. Damman

18 papers receiving 893 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

2025 25 citations Bernd Schnabl, Christopher J. Damman et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Christopher J. Damman

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Damman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Damman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Damman more than expected).

Fields of papers citing papers by Christopher J. Damman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Damman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Damman. The network helps show where Christopher J. Damman may publish in the future.

Co-authorship network of co-authors of Christopher J. Damman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Damman. A scholar is included among the top collaborators of Christopher J. Damman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Damman. Christopher J. Damman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations breakdown → 2025 ·Journal of Clinical Investigation ·Bernd Schnabl, Christopher J. Damman, Rotonya M. Carr	25
2	A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind , randomized, placebo‐controlled trial 2023 ·Diabetes Obesity and Metabolism ·Juan P. Frías, Martin L. Lee, Matthew M. Carter, Emily R. Ebel, (unknown), (unknown), (unknown), Justin L. Sonnenburg, Christopher J. Damman	17
3	Perspective: Nutrition’s Next Chapter – Bioactive Gaps and the Microbiome–Mitochondria Axis 2023 ·Advances in Nutrition ·Christopher J. Damman	2
4	Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans 2018 ·American Journal of Clinical Nutrition ·Johanna W. Lampe, Eunji Kim, Lisa Levy, Laurie A. Davidson, Jennifer S. Goldsby, Fayth L. Miles, Sandi L. Navarro, Timothy W. Randolph, Ni Zhao, Ivan Ivanov, Andrew M. Kaz, Christopher J. Damman, David M. Hockenbery, Meredith A.J. Hullar, Robert S. Chapkin	31
5	Non-endoscopic biopsy techniques: a review 2017 ·Expert Review of Gastroenterology & Hepatology ·(unknown), Yogesh Kumar Verma, (unknown), (unknown), Mireille Rosenberg, Christopher J. Damman, Guillermo J. Tearney	14
6	GUTSS: An Alignment-Free Sequence Comparison Method for Use in Human Intestinal Microbiome and Fecal Microbiota Transplantation Analysis 2016 ·PLoS ONE ·M. Brittnacher, Sonya L. Heltshe, Hillary S. Hayden, Matthew C. Radey, Eli J. Weiss, Christopher J. Damman, Timothy L. Zisman, David L. Suskind, Samuel I. Miller	6
7	Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease 2016 ·Digestive Diseases and Sciences ·David L. Suskind, Ghassan Wahbeh, Stanley A. Cohen, Christopher J. Damman, Jani Klein, (unknown), Michele L. Shaffer, Dale Lee	81
8	The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions 2016 ·Therapeutic Advances in Gastroenterology ·Stephen M. Vindigni, Timothy L. Zisman, David L. Suskind, Christopher J. Damman	169
9	Tropheryma whipplei infection (Whipple's disease) in a patient after liver transplantation 2016 ·Transplant Infectious Disease ·Stephen M. Vindigni, Janelle S. Taylor, Laura A.S. Quilter, Teresa S. Hyun, (unknown), Steven Lawrence Rosinski, Robert M. Rakita, David N. Fredricks, Christopher J. Damman	5
10	Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis 2015 ·PLoS ONE ·Christopher J. Damman, M. Brittnacher, Maria Westerhoff, Hillary S. Hayden, Matthew C. Radey, Kyle R. Hager, Sara Marquis, Samuel I. Miller, Timothy L. Zisman	57
11	Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease 2015 ·Inflammatory Bowel Diseases ·David L. Suskind, M. Brittnacher, Ghassan Wahbeh, Michele L. Shaffer, Hillary S. Hayden, Xuan Qin, Namita Singh, Christopher J. Damman, Kyle R. Hager, Heather Nielson, Samuel I. Miller	185
12	Su1403 Single Colonoscopically Administered Fecal Microbiota Transplant for Ulcerative Colitis-A Pilot Study to Determine Therapeutic Benefit and Graft Stability 2014 ·Gastroenterology ·Christopher J. Damman, M. Brittnacher, Hillary S. Hayden, Matthew C. Radey, (unknown), Samuel I. Miller, Timothy L. Zisman	13
13	Salicylates and the Microbiota: A New Mechanistic Understanding of an Ancient Drug's Role in Dermatological and Gastrointestinal Disease 2013 ·Drug Development Research ·Christopher J. Damman	9
14	The Microbiome and Inflammatory Bowel Disease: Is There a Therapeutic Role for Fecal Microbiota Transplantation? 2012 ·The American Journal of Gastroenterology ·Christopher J. Damman, Samuel I. Miller, Christina M. Surawicz, Timothy L. Zisman	170
15	Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule Ligands 2009 ·SLAS DISCOVERY ·Gregory J. Crowther, Alberto J. Napuli, Andrew P. Thomas, (unknown), (unknown), D.J. Leibly, (unknown), Janhavi Bhandari, Christopher J. Damman, Raymond Hui, Wim G. J. Hol, Frederick S. Buckner, Christophe L. M. J. Verlinde, Zhongsheng Zhang, Erkang Fan, Wesley C. Van Voorhis	36
16	The Gut Microbiota: A Microbial Arsenal Protecting Us From Infectious and Radiation-Induced Diarrhea 2008 ·Gastroenterology ·Christopher J. Damman, Christina M. Surawicz	11
17	Bacteriophages of spirochetes. 2000 ·PubMed ·Christian H. Eggers, Sherwood Casjens, S F Hayes, Claude F. Garon, Christopher J. Damman, D B Oliver, D. Scott Samuels	44
18	Characterization of Borrelia burgdorferi BlyA and BlyB Proteins: a Prophage-Encoded Holin-Like System 2000 ·Journal of Bacteriology ·Christopher J. Damman, Christian H. Eggers, D. Scott Samuels, Donald Oliver	36
19	[ON THE CONCLUSIVENESS OF CLINICAL THYROID FUNCTION TESTS]. 1964 ·PubMed ·R. Kim Guenther, (unknown), (unknown), (unknown), Christopher J. Damman, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact